P

Inventor

WALL MARK J

US21 patents
⚠️ This page may combine multiple inventors who share the name “WALL MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

18 patents
US7795279B2Sep 14, 2010

Method of inhibiting FLT3 kinase

JANSSEN PHARMACEUTICA NV30 citations92
US7662837B2Feb 16, 2010

Inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV26 citations91
US7645755B2Jan 12, 2010

Inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV45 citations91
US11767354B2Sep 26, 2023

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV3 citations83
US11591379B2Feb 28, 2023

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV3 citations83
US11401315B2Aug 2, 2022

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV2 citations83
US10968265B2Apr 6, 2021

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV4 citations83
US10858413B2Dec 8, 2020

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV3 citations83
US10787495B2Sep 29, 2020

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV3 citations83
US10961293B2Mar 30, 2021

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV2 citations73
US12134636B2Nov 5, 2024

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV0 citations72
US7326788B2Feb 5, 2008

Quinolinone derivatives as inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV8 citations71
US11732019B2Aug 22, 2023

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV0 citations62
US7705042B2Apr 27, 2010

Class of arylamide compounds useful as inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV3 citations60
US9526731B2Dec 27, 2016

Method of inhibiting C-KIT kinase

JANSSEN PHARMACEUTICA NV0 citations50
US8933091B2Jan 13, 2015

Method of inhibiting C-KIT kinase

JANSSEN PHARMACEUTICA NV0 citations50
US10875902B2Dec 29, 2020

Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof

JANSSEN PHARMACEUTICA NV0 citations49
US10077241B2Sep 18, 2018

Tetrahydro-benzoimidazolyl modulators of TGR5

JANSSEN PHARMACEUTICA NV0 citations42

ILLIG CARL R

2 patents

JANSSEN SCIENCES IRELAND UNLIMITED CO

1 patent